Literature DB >> 9085551

Rapid identification of measles virus strains by the heteroduplex mobility assay.

S Kreis1, T Whistler.   

Abstract

The continued endemic presence of measles virus (MV), and the large number of isolates which are made in South Africa each year, demanded the use of a rapid and reliable pre-screening technique to select isolates for molecular epidemiological studies by sequence analysis. The heteroduplex mobility assay (HMA) was used to genetically characterize 47 MV isolates collected from three different provinces in South Africa, made between 1986 and 1995. The carboxyl-terminal 590 nt of the nucleocapsid (N) gene--the most variable region of the genome--was amplified by polymerase chain reaction (PCR) and subsequently subjected to HMA analysis for initial genotyping. The results showed three different patterns of heteroduplex formation by gel electrophoresis, representing two distinct wild-type lineages and one group of vaccine-like viruses. Comparison of HMA results with phylogenetic analysis of sequence data for several of the South African MV strains showed a complete correlation of results. The HMA proved to be a useful tool for screening MV isolates for use in molecular epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085551     DOI: 10.1016/s0168-1702(96)01413-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  13 in total

1.  Position and degree of mismatches and the mobility of DNA heteroduplexes.

Authors:  D A Upchurch; R Shankarappa; J I Mullins
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  Heteroduplex mobility assay (HMA) pre-screening: an improved strategy for the rapid identification of inserts selected from phage-displayed peptide libraries.

Authors:  F Fack; S Deroo; S Kreis; C P Muller
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

3.  Combined PCR-heteroduplex mobility assay for detection and differentiation of influenza A viruses from different animal species.

Authors:  J S Ellis; M C Zambon
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns.

Authors:  Alexander A Neverov; Michaela A Riddell; William J Moss; Dmitriy V Volokhov; Paul A Rota; Luis E Lowe; Doris Chibo; Sheilagh B Smit; Diane E Griffin; Konstantin M Chumakov; Vladimir E Chizhikov
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus.

Authors:  Song Chen; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

6.  Use of a heteroduplex mobility assay to detect differences in the fusion protein cleavage site coding sequence among Newcastle disease virus isolates.

Authors:  A Berinstein; H S Sellers; D J King; B S Seal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Heteroduplex panel analysis, a novel method for genetic identification of Aspergillus Section Flavi strains.

Authors:  Y Kumeda; T Asao
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

8.  Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs.

Authors:  Y M Wang; S C Ray; O Laeyendecker; J R Ticehurst; D L Thomas
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

9.  Genetic evolution of structural region of hepatitis C virus in primary infection.

Authors:  Song Chen; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.